Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania

Table 4

Susceptibility data for isolates among HIV patients on prophylaxis and those not on prophylaxis.

	Cotrimoxazole prophylaxis			Crude
	Not on prophylaxis	On prophylaxis
	(%)	(%)		OR (95% CI)
Cotrimoxazole
Resistant	18 (64.3)	36 (81.8)	0.09	1
Susceptible	10 (35.7)	8 (18.2)		2.5 (0.82–7.65)
Amoxycillin-clavulanic acid
Resistant	11 (40.7)	12 (29.3)	0.33	1
Susceptible	16 (59.3)	29 (70.7)		0.60 (0.21–1.69)
Ciprofloxacin
Resistant	8 (33.3)	14 (33.3)	1.00	1
Susceptible	16 (66.7)	44 (66.7)		1 (0.34–2.92)
Ampicillin
Resistant	19 (86.4)	32 (86.5)	0.99	1
Susceptible	3 (13.6)	5 (13.5)		2.47 (0.97–6.28)
Tetracycline
Resistant	14 (82.4)	12 (80.0)	0.87	1
Susceptible	3 (17.6)	3 (20.0)		0.86 (0.14–5.21)